ERK-1/2 activity is required for efficient RSV infection.
D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D050832:Interferon-Stimulated Gene Factor 3; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D010766:Phosphorylation; D018357:Respiratory Syncytial Virus Infections / Q000378:metabolism; D012136:Respiratory Syncytial Viruses / Q000502:physiology*; D015398:Signal Transduction; D014157:Transcription Factors / Q000378:metabolism; D014158:Transcription, Genetic; D015854:Up-Regulation; D014779:Virus Replication
D004791:Enzyme Inhibitors; D050832:Interferon-Stimulated Gene Factor 3; D014157:Transcription Factors; C079868:gamma interferon activation factor; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D020928:Mitogen-Activated Protein Kinases